Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate

被引：0
|
作者：
Espinet, Blanca [1 ,3 ]
Carla Oliveira, Ana [2 ]
Boque, Concepcion [2 ]
Domingo, Alicia [2 ]
Alonso, Esther [2 ]
Sole, Francesc [1 ,3 ]
机构：
[1] Hosp del Mar, Lab Citogenet & Biol Mol, Serv Patol, IMAS,URNHE PRBB, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Hematol, ICO, Barcelona, Spain
[3] Escola Citol Hematol Soledad Woessner IMAS, Barcelona, Spain
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 04期
关键词：
chronic myeloid leukemia; clonal cytogenetic abnormalities; imatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The emergence of clonal chromosomal abnormalities in Philadelphia-negative cells during treatment with imatinib in patients with Philadelphia-positive chronic myeloid leukemia has been reported. We add information to this issue presenting a series of 29 patients in complete cytogenetic response after imatinib treatment, three of whom developed clonal aberrations.
引用
收藏
页码：556 / 558
页数：4
相关论文
共 50 条
  • [1] Hematologic and cytogenetic response to imatinib mesylate in chronic myeloid leukemia
    Narayanan, G.
    Chacko, D. J.
    Koshy, A. A.
    Soman, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S18 - S18
  • [2] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [3] Cytogenetic clonal evolution in chronic myeloid leukemia during imatinib mesylate treatment.
    Klamova, H
    Brezinova, J
    Michalova, K
    Zemanova, Z
    Trneny, M
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [4] Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response
    Sanchez-Guijo, Fermin M.
    Hernandez, Jesus M.
    Lumbreras, Eva
    Morais, Patricia
    Santamaria, Carlos
    Garcia, Juan-Luis
    Gutierrez, Norma C.
    Miguel, Jesus F. San
    del Canizo, Maria-Consuelo
    LEUKEMIA RESEARCH, 2009, 33 (01) : 170 - 173
  • [5] Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib
    Loriaux, M
    Deininger, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2197 - 2203
  • [6] Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities
    Pawarode, Attaphol
    Sait, Sheila N. J.
    Nganga, Alain
    Coignet, Lionel J.
    Barcos, Maurice
    Baer, Maria R.
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1589 - 1592
  • [7] Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate
    Perseghin, P
    Gambacorti-Passerini, C
    Tornaghi, L
    Dassi, M
    Pioltelli, P
    Parma, M
    Colnaghi, T
    Giudici, G
    Elli, E
    Fumagalli, M
    Ponchio, L
    Biondi, A
    Pogliani, EM
    TRANSFUSION, 2005, 45 (07) : 1214 - 1220
  • [8] Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment
    Colombat, M
    Fort, MP
    Chollet, C
    Marit, G
    Roche, C
    Preudhomme, C
    Reiffers, J
    Praloran, V
    Mahon, FX
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 162 - 168
  • [9] Prognostic Factors Associated with Complete Cytogenetic Response in Patients with Chronic Myelogenous Leukemia on Imatinib Mesylate Therapy
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (5-6) : 305 - 308
  • [10] Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate
    Morimoto, A
    Ogami, A
    Chiyonobu, T
    Takanashi, M
    Sugimoto, T
    Imamura, T
    Ishida, H
    Yoshihara, T
    Imashuku, S
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (05) : 320 - 322
12345